Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T, Sada KE, Yan M, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Watanabe H, Katsuyama E, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Miyake K, Kiguchi T, Wada J. Katsuyama T, et al. Among authors: katsuyama e. Mod Rheumatol. 2017 Sep;27(5):773-777. doi: 10.1080/14397595.2016.1259714. Epub 2016 Dec 15. Mod Rheumatol. 2017. PMID: 27846761
Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis.
Ohashi K, Sada KE, Nakai Y, Matsushima S, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Miyawaki Y, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Tatebe N, Narazaki M, Matsumoto Y, Sunahori Watanabe K, Kawabata T, Wada J. Ohashi K, et al. Among authors: katsuyama e, katsuyama t. J Clin Rheumatol. 2019 Sep;25(6):246-251. doi: 10.1097/RHU.0000000000000836. J Clin Rheumatol. 2019. PMID: 29933322
Association of explanatory histological findings and urinary protein and serum creatinine levels at renal biopsy in lupus nephritis: a cross-sectional study.
Katsuyama E, Miyawaki Y, Sada KE, Asano Y, Hayashi K, Yamamura Y, Hiramatsu-Asano S, Morishita M, Ohashi K, Watanabe H, Katsuyama T, Narazaki M, Matsumoto Y, Wada J. Katsuyama E, et al. Among authors: katsuyama t. BMC Nephrol. 2020 Jun 1;21(1):208. doi: 10.1186/s12882-020-01868-9. BMC Nephrol. 2020. PMID: 32487161 Free PMC article.
A case of recurrent IgG4-related disease successfully treated with belimumab after remission of systemic lupus erythematosus.
Katayama Y, Katsuyama T, Shidahara K, Nawachi S, Asano Y, Ohashi K, Miyawaki Y, Katsuyama E, Narazaki M, Matsumoto Y, Sada KE, Wada J. Katayama Y, et al. Among authors: katsuyama e, katsuyama t. Rheumatology (Oxford). 2022 Oct 6;61(10):e308-e310. doi: 10.1093/rheumatology/keac284. Rheumatology (Oxford). 2022. PMID: 35595251 No abstract available.
Immunosuppressive Treatment for an anti-U1 Ribonucleoprotein Antibody-positive Patient with Pulmonary Arterial Hypertension.
Matsumoto K, Miyawaki Y, Katsuyama T, Nakadoi T, Shidahara K, Hirose K, Nawachi S, Asano Y, Katayama Y, Katsuyama E, Takano-Narazaki M, Matsumoto Y, Mori A, Akagi S, Sada KE, Wada J. Matsumoto K, et al. Among authors: katsuyama e. Intern Med. 2024 Mar 1;63(5):671-676. doi: 10.2169/internalmedicine.1407-22. Epub 2023 Jul 19. Intern Med. 2024. PMID: 37468249 Free PMC article.
Infliximab biosimilar-induced lupus nephritis: A case report.
Shidahara K, Katsuyama T, Hirose K, Matsumoto K, Nawachi S, Nakadoi T, Asano Y, Katayama Y, Miyawaki Y, Katsuyama E, Takano-Narazaki M, Matsumoto Y, Sada KE, Wada J. Shidahara K, et al. Among authors: katsuyama e. Mod Rheumatol Case Rep. 2023 Dec 29;8(1):74-76. doi: 10.1093/mrcr/rxad061. Mod Rheumatol Case Rep. 2023. PMID: 37902434
A case of sitosterolaemia-caused systemic large-vessel stenosis mimicking Takayasu arteritis in which FDG-PET provided a clue for the differential diagnosis.
Nakadoi T, Katsuyama E, Matsumoto K, Shidahara K, Hirose K, Nawachi S, Asano Y, Katayama Y, Miyawaki Y, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Sada KE, Tada H, Wada J. Nakadoi T, et al. Among authors: katsuyama e. Rheumatol Adv Pract. 2023 Nov 10;7(3):rkad096. doi: 10.1093/rap/rkad096. eCollection 2023. Rheumatol Adv Pract. 2023. PMID: 38089753 Free PMC article. No abstract available.
Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis.
Tatebe N, Sada KE, Asano Y, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Narazaki M, Watanabe K, Kawabata T, Wada J. Tatebe N, et al. Among authors: katsuyama e, katsuyama t. Mod Rheumatol. 2018 Jan;28(1):141-146. doi: 10.1080/14397595.2017.1317377. Epub 2017 May 2. Mod Rheumatol. 2018. PMID: 28463039 Free article.
76 results